Abstract
Background Gastric cancer is a leading cause of cancer-related mortality, and current treatment outcomes for advanced disease remain poor. HER2 has been identified as a potential candidate for targeted therapy in gastric cancers displaying HER2 gene amplification and protein overexpression.
Original language | English |
---|---|
Pages (from-to) | 839-842 |
Number of pages | 4 |
Journal | Journal of Clinical Pathology |
Volume | 63 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sept 2010 |
ASJC Scopus subject areas
- Pathology and Forensic Medicine